{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "position" : "CT domain",
      "modification_type" : "ubiquitination"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q10589",
      "entity_text" : "BST-2",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:11309" ],
      "Cellular_component" : [ "go:GO:0009986" ]
    }
  },
  "verbose_text" : "Other BST-2 antagonists include KSHV K5 protein, which ubiquitinates K18 residue in the CT domain of BST-2, leading to reduced surface and intracellular levels of BST-2, presumably through an endolysosomal process.",
  "reading_complete" : "2020-08-08T14:07:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:06:07Z",
  "trigger" : "ubiquitinates",
  "evidence" : [ "ubiquitinates K18 residue in the CT domain of BST-2" ],
  "pmc_id" : "3235769",
  "score" : 0
}